Incyte (INCY) EBIT Margin (2010 - 2026)
Incyte posted quarterly EBIT Margin of 23.66% for Q1 2026, up 417.0% year-on-year from 4.58% in Q1 2025, and up 6.15% on a QoQ basis from 22.29% in Q4 2025.
Incyte (INCY) has 17 years of EBIT Margin data on file, last reported at 23.66% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin rose 417.0% year-over-year to 23.66%; the trailing twelve-month figure through Mar 2026 stood at 30.05% (up 2609.0% YoY), and the FY2025 full-year result was 29.46%, up 2802.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 23.66%, up from 22.29% in the prior quarter.
- Across five years, EBIT Margin topped out at 43.63% in Q2 2025 and bottomed at 45.81% in Q2 2024.
- The 5-year median for EBIT Margin is 19.49% (2025), against an average of 16.35%.
- The widest annual swing landed in 2024, when EBIT Margin sank 6611 bps; it then surged 8944 bps in 2025.
- A 5-year view of EBIT Margin shows it stood at 7.56% in 2022, then jumped by 144 bps to 18.48% in 2023, then soared by 38 bps to 25.58% in 2024, then fell by 13 bps to 22.29% in 2025, then climbed by 6 bps to 23.66% in 2026.
- The last three EBIT Margin figures came in at 23.66% (Q1 2026), 22.29% (Q4 2025), and 32.47% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.02% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 23.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.66% |
| Dec 31, 2025 | 22.29% |
| Sep 30, 2025 | 32.47% |
| Jun 30, 2025 | 43.63% |
| Mar 31, 2025 | 19.49% |
| Dec 31, 2024 | 25.58% |
| Sep 30, 2024 | 12.84% |
| Jun 30, 2024 | -45.81% |
| Mar 31, 2024 | 10.43% |
| Dec 31, 2023 | 18.48% |
| Sep 30, 2023 | 23.36% |
| Jun 30, 2023 | 20.30% |
| Mar 31, 2023 | 3.06% |
| Dec 31, 2022 | 7.56% |
| Sep 30, 2022 | 16.81% |
| Jun 30, 2022 | 27.92% |
| Mar 31, 2022 | 15.89% |
| Dec 31, 2021 | 12.83% |
| Sep 30, 2021 | 28.96% |
| Jun 30, 2021 | 19.96% |
| Mar 31, 2021 | 16.34% |
| Dec 31, 2020 | 20.80% |
| Sep 30, 2020 | 0.86% |
| Jun 30, 2020 | 33.54% |
| Mar 31, 2020 | -116.80% |
| Dec 31, 2019 | 16.40% |
| Sep 30, 2019 | 24.35% |
| Jun 30, 2019 | 18.61% |
| Mar 31, 2019 | 14.88% |
| Dec 31, 2018 | -4.36% |
| Sep 30, 2018 | 6.92% |
| Jun 30, 2018 | 15.96% |
| Mar 31, 2018 | -17.56% |
| Dec 31, 2017 | 0.38% |
| Sep 30, 2017 | 3.94% |
| Jun 30, 2017 | 2.22% |
| Mar 31, 2017 | -34.69% |
| Dec 31, 2016 | -20.01% |
| Sep 30, 2016 | 8.27% |
| Jun 30, 2016 | 18.10% |
| Mar 31, 2016 | 13.68% |
| Dec 31, 2015 | 7.00% |
| Sep 30, 2015 | -0.05% |
| Jun 30, 2015 | -4.54% |
| Mar 31, 2015 | -4.35% |
| Dec 31, 2014 | -20.67% |
| Sep 30, 2014 | 35.30% |
| Jun 30, 2014 | -26.30% |
| Mar 31, 2014 | -25.54% |
| Dec 31, 2013 | -29.91% |
| Sep 30, 2013 | -15.49% |
| Jun 30, 2013 | 17.03% |
| Mar 31, 2013 | -5.76% |
| Dec 31, 2012 | 11.99% |
| Sep 30, 2012 | -16.76% |
| Jun 30, 2012 | 17.59% |
| Mar 31, 2012 | -94.50% |
| Dec 31, 2011 | -152.79% |
| Sep 30, 2011 | -250.89% |
| Jun 30, 2011 | -244.57% |
| Mar 31, 2011 | -49.49% |
| Dec 31, 2010 | 19.93% |
| Sep 30, 2010 | -130.73% |
| Jun 30, 2010 | 27.33% |
| Mar 31, 2010 | -114.70% |